Sees Q4 organic sales growth of low double digits. Says U.S. Libre user base has doubled in the last two years. Says very strong quarter. Says base business has grown double digits three quarters in a row. Says a lot of focus on gross margin and gross margin expansion. Comments and guidance taken from Q3 earnings conference call.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ABT:
- Early notable gainers among liquid option names on October 18th
- Unusually active option classes on open October 18th
- Abbott reports Q3 worldwide Medical Devices sales up 16.6% on reported basis
- Abbott narrows FY23 adjusted EPS view to $4.42-$4.46 from $4.30-$4.50
- Abbott reports Q3 adjusted EPS $1.14, consensus $1.04